Facebook Instagram Pinterest Reddit Tumblr X Youtube
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 198

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Keeping Up with the Feds: From FDA to HRSA, Washington Backs Psychedelics

The Rush for Iboga Looks Different from Gabon

FDA Issues Final Psychedelics Guidance, Schedules September Hearing on the Future of Psychedelic Therapies

Pα+ Psychedelic Bulletin #227: A Closer Look at Compass’ 6-Month Data; AtaiBeckley Deal Update; ‘Rysanso’ Brand MDMA?

Compass Closes Out Phase 3 With 6-Month COMP006 Data, Eyes H1’27 Launch

Reclaiming Ownership of Your Body With Psychedelics

Tackling Trauma with Pharmahuasca and DMT

World’s First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder...

PT295 – Sidarta Ribeiro – Dreams, LSD, and Biopiracy

Psychedelic Bulletin: Tracking LSD Patents; Psilocybin Effective for a Year in...

PT294 – Andrew Tatarsky, Ph.D. & Juliana Mulligan – Vital Psychedelic...

HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S....

Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access...

Trauma and Vulnerability to Suggestion: Redefining How We Understand Consent

COMPASS Pathways plc to announce fourth quarter and full year 2021...

Load more

EDITOR PICKS

Keeping Up with the Feds: From FDA to HRSA, Washington Backs...

The Rush for Iboga Looks Different from Gabon

FDA Issues Final Psychedelics Guidance, Schedules September Hearing on the Future...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    Facebook Instagram Pinterest Reddit Tumblr X Youtube
    ©